CJJD: AI 评分 42/100 — AI 分析 (4月 2026)

China Jo-Jo Drugstores, Inc. operates as a retailer and distributor of pharmaceutical and healthcare products in China. The company's segments include retail drugstores, online pharmacy, drug wholesale, and herb farming.

Key Facts: AI Score: 42/100 Sector: Healthcare

公司概况

概要：

China Jo-Jo Drugstores, Inc. retails and distributes pharmaceutical and healthcare products in China, operating through retail drugstores, online platforms, wholesale, and herb farming. With a focus on traditional Chinese medicine (TCM) and Western medicine, the company operates retail pharmacies and online stores, facing competition in China's evolving healthcare market.

CJJD是做什么的？

Founded in 2003 and headquartered in Hangzhou, China, China Jo-Jo Drugstores, Inc. has evolved into a multifaceted healthcare company operating across various segments of the pharmaceutical industry. The company's primary business involves retailing and distributing pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices. These products are offered through its network of retail drugstores, operating under the Jiuzhou Grand Pharmacy name, and its online pharmacy platforms. The company also provides convenience products, such as consumable, seasonal, and promotional items. China Jo-Jo Drugstores distinguishes itself by integrating traditional and Western medical practices, offering on-site consultations with licensed doctors of Western medicine and TCM. This approach caters to a broad customer base seeking both conventional and alternative healthcare solutions. In addition to its retail operations, the company engages in drug wholesale, distributing third-party pharmaceutical products to trading companies. It also cultivates and wholesales herbs used for TCM, further diversifying its revenue streams. As of March 31, 2021, China Jo-Jo Drugstores operated 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, along with 4 additional drugstores, demonstrating its established presence in the Chinese pharmaceutical retail market.

CJJD的投资论点是什么？

China Jo-Jo Drugstores, Inc. presents a unique investment proposition within the Chinese healthcare market, characterized by its integrated approach to retail pharmacy, online sales, wholesale distribution, and herb farming. With a market capitalization of $0.01 billion and a P/E ratio of 1.20, the company's valuation metrics suggest potential undervaluation relative to its earnings. The company's profit margin of 8.5% and gross margin of 3.2% indicate areas for improvement in operational efficiency and cost management. Key growth catalysts include expanding its online pharmacy presence to capitalize on the growing e-commerce trend in China, and leveraging its TCM herb farming operations to meet increasing demand for traditional medicine. However, the may be worth researching potential risks associated with operating in a highly regulated market, including evolving healthcare policies and pricing pressures. The company's beta of -0.15 suggests a low correlation with the broader market, potentially offering downside protection during market downturns.

CJJD在哪个行业运营？

China Jo-Jo Drugstores operates within the rapidly evolving Chinese healthcare market, which is characterized by increasing demand for pharmaceutical products and healthcare services. The market is driven by factors such as an aging population, rising disposable incomes, and growing awareness of health and wellness. The competitive landscape includes both domestic and international players, ranging from large pharmaceutical manufacturers to retail pharmacy chains. China Jo-Jo Drugstores differentiates itself through its integrated business model, combining retail pharmacy, online sales, wholesale distribution, and herb farming. The company's focus on traditional Chinese medicine (TCM) also provides a unique selling proposition in a market where TCM remains highly valued.

Medical - Pharmaceuticals

Healthcare

CJJD有哪些增长机遇？

Expansion of Online Pharmacy Platform: China Jo-Jo Drugstores can capitalize on the increasing e-commerce penetration in China by expanding its online pharmacy platform. The Chinese online pharmacy market is projected to reach $49.7 billion in 2026, presenting a significant growth opportunity. By enhancing its online platform with a wider range of products, improved user experience, and strategic partnerships with e-commerce giants, the company can attract a larger customer base and drive online sales growth. Timeline: Ongoing.
Leveraging Traditional Chinese Medicine (TCM): With the growing popularity of TCM in China and globally, China Jo-Jo Drugstores can leverage its herb farming operations to meet the increasing demand for TCM products. The global TCM market is expected to reach $200 billion by 2025. By expanding its herb cultivation and processing capabilities, the company can ensure a stable supply of high-quality TCM ingredients and develop new TCM-based products for both domestic and international markets. Timeline: Ongoing.
Strategic Partnerships and Acquisitions: China Jo-Jo Drugstores can pursue strategic partnerships and acquisitions to expand its market reach and product offerings. Collaborating with other healthcare providers, pharmaceutical manufacturers, or technology companies can create synergies and enhance the company's competitive position. Acquiring smaller pharmacy chains or healthcare-related businesses can accelerate its expansion into new geographic areas or product categories. Timeline: Upcoming.
Enhancing Retail Pharmacy Network: While already having a retail presence, China Jo-Jo Drugstores can optimize its existing network of retail pharmacies by improving store layouts, product assortment, and customer service. Implementing data analytics to understand customer preferences and optimize inventory management can enhance sales and profitability. Expanding the range of healthcare services offered at its pharmacies, such as health screenings and consultations, can also attract more customers. Timeline: Ongoing.
Expanding Drug Wholesale Business: China Jo-Jo Drugstores can increase its revenue by expanding its drug wholesale business. By establishing partnerships with more pharmaceutical manufacturers and distributors, the company can increase the volume of products it distributes. Focusing on niche or specialized pharmaceutical products can also provide a competitive advantage. Timeline: Ongoing.

Market capitalization of $0.01 billion, indicating a small-cap company with potential for growth.
P/E ratio of 1.20, suggesting the company may be undervalued compared to its earnings.
Profit margin of 8.5%, reflecting the company's profitability in the pharmaceutical retail sector.
Gross margin of 3.2%, indicating the percentage of total sales revenue that the company retains after incurring the direct costs associated with producing the goods and services it sells.
Operated 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores as of March 31, 2021, demonstrating a significant retail presence.

CJJD提供哪些产品和服务？

Operates retail drugstores under the Jiuzhou Grand Pharmacy name.
Sells prescription and over-the-counter drugs.
Offers nutritional supplements and traditional Chinese medicines (TCM).
Provides personal and family care products and medical devices.
Operates an online drugstore retailing OTC drugs and nutritional supplements.
Sells products through third-party online platforms.
Distributes third-party pharmaceutical products to trading companies.
Cultivates and wholesales herbs used for TCM.

CJJD如何赚钱？

Retail sales of pharmaceutical products through physical stores.
Online sales of pharmaceutical products through its online pharmacy.
Wholesale distribution of pharmaceutical products to other companies.
Cultivation and sale of herbs used in traditional Chinese medicine.

Individual consumers seeking prescription and over-the-counter medications.
Customers interested in nutritional supplements and personal care products.
Patients seeking traditional Chinese medicine (TCM) remedies.
Trading companies purchasing pharmaceutical products for distribution.

Established retail pharmacy network in China.
Integration of traditional Chinese medicine (TCM) with Western medicine.
Online pharmacy platform providing convenient access to healthcare products.
Herb farming operations ensuring a stable supply of TCM ingredients.

什么因素可能推动CJJD股价上涨？

Upcoming: Expansion of online pharmacy platform to increase market reach and sales.
Ongoing: Leveraging TCM expertise to develop new products and services for domestic and international markets.
Upcoming: Strategic partnerships with other healthcare providers or technology companies to enhance capabilities.
Ongoing: Efforts to improve operational efficiency and increase profit margins.

CJJD的主要风险是什么？

Potential: Intense competition from other pharmaceutical retailers and online pharmacies.
Ongoing: Evolving healthcare regulations and pricing pressures in China.
Potential: Product recalls or safety concerns related to pharmaceutical products.
Potential: Fluctuations in the cost of raw materials for TCM herbs.
Ongoing: Dependence on regulatory approvals for pharmaceutical products.

CJJD的核心优势是什么？

Established retail pharmacy network in China.
Integration of traditional Chinese medicine (TCM) with Western medicine.
Online pharmacy platform providing convenient access to healthcare products.
Herb farming operations ensuring a stable supply of TCM ingredients.

CJJD的劣势是什么？

Relatively small market capitalization compared to larger competitors.
Gross margin of 3.2% indicates potential inefficiencies.
Limited geographic diversification outside of China.
Dependence on regulatory approvals for pharmaceutical products.

CJJD有哪些机遇？

Expansion of online pharmacy platform to reach more customers.
Leveraging TCM expertise to develop new products and services.
Strategic partnerships and acquisitions to expand market reach.
Increasing demand for healthcare products and services in China.

CJJD面临哪些威胁？

Intense competition from other pharmaceutical retailers and online pharmacies.
Evolving healthcare regulations and pricing pressures in China.
Potential for product recalls or safety concerns.
Fluctuations in the cost of raw materials for TCM herbs.

CJJD的竞争对手是谁？

Agile Therapeutics, Inc. — Focuses on women's healthcare products. — (AGRX)
Apogee Therapeutics, Inc. — Develops therapies for autoimmune and inflammatory diseases. — (APGN)
Centogene N.V. — Specializes in genetic diagnostics for rare diseases. — (CNTG)
ETAO International Co., Ltd. — Provides digital healthcare solutions in China. — (ETAO)
Frontage Holdings Corporation — Offers contract research services to pharmaceutical companies. — (FTRP)

Key Metrics

MoonshotScore: 42/100

Company Profile

CEO: Lei Liu
Headquarters: Hangzhou, CN
Employees: 939
Founded: 2009

AI Insight

AI analysis pending for CJJD

常见问题

What does China Jo-Jo Drugstores, Inc. do?

China Jo-Jo Drugstores, Inc. operates as a retailer and distributor of pharmaceutical and healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours.

What do analysts say about CJJD stock?

AI analysis is pending for CJJD. Therefore, a neutral summary of analyst consensus, key valuation metrics, and growth considerations is not currently available. Investors should conduct their own due diligence and consult with financial professionals before making any investment decisions. Further information will be provided as it becomes available.

What are the main risks for CJJD?

China Jo-Jo Drugstores faces several risks inherent to the pharmaceutical retail and distribution industry in China. These include intense competition from both domestic and international players, evolving healthcare regulations and pricing pressures, potential for product recalls or safety concerns, and fluctuations in the cost of raw materials for TCM herbs. The company's dependence on regulatory approvals for pharmaceutical products also poses a risk to its operations and growth prospects. Investors should carefully consider these risks before investing in CJJD.

How does China Jo-Jo Drugstores, Inc. ensure the quality and safety of its pharmaceutical products?

China Jo-Jo Drugstores, Inc. operates in a highly regulated industry and is subject to stringent quality control standards and regulations. While specific details on the company's quality assurance processes are not available, it is expected that the company adheres to all applicable regulations and implements measures to ensure the safety and efficacy of its pharmaceutical products. This includes sourcing products from reputable suppliers, conducting quality testing, and maintaining proper storage and handling procedures. Compliance with these standards is essential for maintaining the company's reputation and avoiding potential liabilities.

What revenue streams does China Jo-Jo Drugstores, Inc. have in healthcare?

China Jo-Jo Drugstores, Inc. generates revenue from multiple streams within the healthcare sector. The primary revenue stream is the retail sale of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, and medical devices, through its network of retail drugstores. The company also generates revenue from its online pharmacy platform, selling OTC drugs and nutritional supplements. Additional revenue streams include the wholesale distribution of pharmaceutical products to trading companies and the cultivation and sale of herbs used in traditional Chinese medicine (TCM).